DKK1 and cancer: Although the effects of DKK-1 pharmacological inhibition have not been evaluated in cancer, it has been shown that WAY-262611 inhibits both cell migration and expression of focal adhesion kinase (FAK) in fibroblast-like synoviocytes [4].